Regeneron, Intellia target neurological diseases in expanded gene editing deal
BioPharma Dive,
Regeneron Pharmaceuticals and Intellia Therapeutics are again expanding a longstanding research partnership, this time with a…
Alzheimer’s: Scientists find way to switch some diseased cells back to…
Medical News Today,
Share on PinterestMicroglia are thought to be key drivers of many neurological conditions, including Alzheimer’s disease.
Lo que no nos mata nos podría hacer más fuertes: terapia génica con virus
TheObjective,
Existen más virus que estrellas en el universo. Para hacernos una idea de la cantidad tan ingente que hay, cualquiera que lea…
